No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Kristen Brennand, Ph.D. - brain & behavior research expert on schizophrenia
Kristen Brennand, Ph.D.
April 17, 2014
A new study published online April 1st in Molecular Psychiatry by 2012 NARSAD Young Investigator Grantee Kristen Brennand, Ph.D., and 2013 NARSAD Distinguished...
Richard S. Lee, Ph.D., expert in brain research
Richard S. Lee, Ph.D.
April 14, 2014
It is widely believed that the brain is biologically affected and altered by stress, but it is very difficult to “see into the brain” to identify the processes...
Christopher Pack, Ph.D., expert on schizophrenia research
Christopher Pack, Ph.D.
April 10, 2014
Recent research led by Christopher Pack, Ph.D., of McGill University, supported in part by his 2008 NARSAD Young Investigator Grant, may help to explain why...
Theodore D. Satterthwaite, M.D.
Theodore D. Satterthwaite, M.D.
April 09, 2014
2010 NARSAD Young Investigator Grantee Theodore D. Satterthwaite, M.D., of the University of Pennsylvania, led research that demonstrated specific gender...
Akira Sawa, M.D., Ph.D., expert on schizophrenia research
Akira Sawa, M.D., Ph.D.
April 07, 2014
In new research led by 2011 NARSAD Distinguished Investigator Grantee Akira Sawa, M.D., Ph.D., an experimental anticancer medication has been found to reverse...

Pages

Subscribe to